ArticleAnnals of hematology2022

Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study.

Alexander Röth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.